March 16 (Reuters) - iBio Inc IBIO.O:
IBIO TO PROVIDE AN UPDATE ON CARDIOPULMONARY PROGRAM TARGETING PULMONARY HYPERTENSION ASSOCIATED WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (PH-HFPEF)
IBIO INC - EXPECTS TO DECLARE BISPECIFIC ANTIBODY CANDIDATE FOR PH-HFPEF IN Q3 2026